about
Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitisA microchip CD4 counting method for HIV monitoring in resource-poor settings.Differential sensitivity of breast cancer cells to tumor necrosis factor-alpha: involvement of protein kinase C.Locating the right phrenic nerve by imaging the right pericardiophrenic artery with computerized tomographic angiography: implications for balloon-based procedures.Quality of life and patient-centered outcomes following atrial fibrillation ablation: short- and long-term perspectives to improving care.Variant rs2200733 on chromosome 4q25 confers increased risk of atrial fibrillation: evidence from a meta-analysis.Ablation for Atrial Fibrillation: Termination of Atrial Fibrillation is Not the End Point.Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study.Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival.Cisplatin resistance is associated with deregulation in protein kinase C-delta.Ablation as First-Line Therapy for Atrial Fibrillation: Yes.Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation.Disposable polydimethylsiloxane/silicon hybrid chips for protein detection.Application of microchip assay system for the measurement of C-reactive protein in human saliva.Toward the development of a lab-on-a-chip dual-function leukocyte and C-reactive protein analysis method for the assessment of inflammation and cardiac risk.Catheter ablation of atrial fibrillation in patients with mechanical mitral valve: long-term outcome of single procedure of pulmonary vein antrum isolation with or without nonpulmonary vein trigger ablation.Atrial fibrillation and the risk of incident dementia: a meta-analysis.Outcomes of atrio-esophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stentingSafety of catheter ablation for atrial fibrillation in the octogenarian populationArrhythmogenecity and thrombogenicity of the residual left atrial appendage stump following surgical exclusion of the appendage in patients with atrial fibrillationThromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendageAssociation between prolonged P wave duration and left atrial scarring in patients with paroxysmal atrial fibrillationOral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysisEndo-Epicardial Ablation versus Endocardial Ablation for the Management of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy: A Systematic Review and Meta-AnalysisCavotricuspid Isthmus Ablation in Atrial Fibrillation With or Without Typical Atrial Flutter: A Meta-analysis
P50
Q23918874-8BAA9770-EE9C-4C71-AD82-0858053851A7Q24812883-65980EE0-7E80-4606-A179-BEE876F15A2AQ31856143-B2D757B1-5477-4753-ABAE-6C5D0BE85DEAQ33546944-975BBE29-B5B0-4BB6-9506-937E564661D3Q38036333-84740173-F820-4C32-B674-2F74C153B03FQ38058113-00061B22-4979-4EE6-9706-9EF602869988Q39950204-A2CBF232-318A-4E1E-958C-CBDC95B37222Q44204171-CF3F2582-C174-4F5E-8FFA-2FE3632808ACQ44264820-E76B089F-C25C-48B3-AAA1-CEC3613B98E1Q44814283-1FA13239-4D04-4E84-91E3-61CBE389B45CQ45965188-42CE0B2D-31A5-4C48-B635-6B62A532C2A1Q46706301-F296E6B7-E561-404D-BDFF-D47644B3B63DQ48633020-41CA3807-DB28-4276-8B21-88CD1AC93E94Q51344466-7DFECB85-1D68-4A4E-BDCE-7ACD1D1C7E12Q51537383-18973A33-B83E-4F8E-9202-BC7823C0F6E7Q51589907-17FEF1C5-2C9C-4514-B471-6A1EEBAF0029Q51742210-92FABB64-B192-494B-8B67-3CB8AC1635F2Q53103768-DE1262A9-E71C-4014-BE8A-1B7C5F724D60Q87451759-D0F48677-02A9-4ABE-A273-6C8C2F891FC3Q90047843-C804C9BE-0124-4C5B-B487-086A4AB4F87FQ90690706-08074720-C959-455A-BE1E-6FEBE397F96DQ90955340-A5A39E48-4ED7-4BF2-A544-39895DF4784CQ91921540-1876B29F-D3D2-4370-B7FB-3D62600EEEE6Q93141769-B208D1B1-B17F-44A7-AB38-16B759480840Q96027199-04C1CFD4-F575-489D-9FF3-8E7F9F4D4A16Q96340482-012B233B-33C1-4A80-96E8-E72C547300A8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sanghamitra Mohanty
@ast
Sanghamitra Mohanty
@en
Sanghamitra Mohanty
@es
Sanghamitra Mohanty
@nl
Sanghamitra Mohanty
@sl
সংঘমিত্রা মোহান্তি
@bn
type
label
Sanghamitra Mohanty
@ast
Sanghamitra Mohanty
@en
Sanghamitra Mohanty
@es
Sanghamitra Mohanty
@nl
Sanghamitra Mohanty
@sl
সংঘমিত্রা মোহান্তি
@bn
prefLabel
Sanghamitra Mohanty
@ast
Sanghamitra Mohanty
@en
Sanghamitra Mohanty
@es
Sanghamitra Mohanty
@nl
Sanghamitra Mohanty
@sl
সংঘমিত্রা মোহান্তি
@bn
P1053
D-1122-2015
P106
P1153
36171775500
P31
P3829
P496
0000-0001-6601-944X